Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Steve ElmsDirector | Marker TherapeuticsMRKR | Open-market buy | 24/12/23 | 24/12/26 | 11,085 sh | $3.20 | $35,472 | +3.5% |
Scott D. Sandell10% Owner | Marker TherapeuticsMRKR | Open-market buy | 24/12/23 | 24/12/23 | 554,250 sh | $3.20 | $1,773,600 | +51.7% |
Norman David EansorDirector | Marker TherapeuticsMRKR | Open-market buy | 21/03/16 | 23/06/08 | 14,285 sh | $17.50 | $249,987.5 | +588.3% |